People with diabetes face a higher risk of diabetic retinopathy, and semaglutide use is linked to a rare but serious optic nerve condition called NAION
Genetic insights help PlexusDx providers anticipate how your body may respond to semaglutide or tirzepatide, potentially accelerating the time to your ideal dose and reducing trial-and-error adjustments
Its major compound "Curcumin", acts to restore adequate glutathione levels and enhance glutathione enzyme activity
The Obesity Cohort Produced One of the Strongest Signals Among patients with breast cancer and obesity, GLP-1 receptor agonist use was associated with a substantially lower hazard of all-cause mortality compared with nonuse
Reported side effects are typically mild and transient: BPC-157: Nausea (rare), mild fatigue in the first week, minor injection site redness TB-500: Mild lethargy during the loading phase, transient head rush immediately after injection, injection site discomfort Combined stack: No documented synergistic toxicity in preclinical or clinical observational data The more significant risks relate to sourcing and administration rather than the peptides themselves
Support for gut lining health, which can improve absorption of dietary protein on aggressive nutrition plans